Pedro Nazareth Aguiar Junior

9PUBLICATIONS
24CO-AUTHORS
Traditional Chinese medicine and treatmentsGene and molecular therapyCancer geneticsDisease surveillancePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 13, 2024
Natural supplementation to effectively treat cancer-induced fatigue: evidence of a meta-analysis on the use of guaraná.

Jean Henri Maselli-Schoueri, Pedro Nazareth Aguiar Junior, Auro Del Giglio

|Oct 19, 2023
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective.

Bruna Bianca Lopes David, Pedro Nazareth Aguiar Junior, Matheus Costa E Silva

|Aug 21, 2023
Challenges and opportunities in building a health economic framework for personalized medicine in oncology.

Pedro Nazareth Aguiar, Silvio Matsas, Rodrigo Dienstmann

|May 15, 2023
Physical Examination in Medical Oncology Guiding the Development of a Protocol for Teleoncology Care in a Public Health Care Oncology Service.

Pedro Nazareth Aguiar, Mirella Stival, Marcos Aurelio Fonseca Magalhães Filho

|Jun 08, 2022
Laboratory variables as predictors of progression in gastroenteropancreatic neuroendocrine tumors in different lines of antineoplastic treatments.

Daniela Pezzutti Domigues Armentano, Mariana Ribeiro Monteiro, Pedro Nazareth Aguiar

|May 11, 2022
Cost-effectiveness analysis of Ado-trastuzumab emtansine for the treatment of residual invasive HER2-positive breast cancer.

Marcos Aurélio Fonseca Magalhães Filho, Pedro Nazareth Aguiar, Milena Brachmans Mascarenhas Neves

Pageof 2